Insider trade

Officer received an award of 1,638 TMO shares

Traded Feb 25, 2026 · Filed Feb 27, 2026

Thermo Fisher ScientificTMO

1,638
Shares

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Feb 25, 2026
Reporting period: Not applicable
Filed with the SEC: Feb 27, 2026

OfficerGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0000097745-26-000034
Filed / recorded

Feb 27, 2026, 10:04 PM UTC

Added to OQRO

Oct 2, 2026, 12:28 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

THERMO FISHER SCIENTIFIC INC.

Issuer CIK

97745

Ticker

TMO

Reporting person

Frederick M. Lowery

Relationship

Officer

Officer title

Executive Vice President

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Feb 25, 2026

Transaction code

A

Shares / units

1,638

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

15,941.3724

Ownership form

Direct

Amendment

No

Footnotes from the filing

Shares represent a performance-based restricted stock unit award granted on February 19, 2025. On February 25, 2026, the Compensation Committee certified achievement of the applicable performance criteria. The award vests in three equal tranches on February 28, 2026, 2027 and 2028, in accordance with the terms of the award agreement.
Shares represent an adjustment to the final tranche of a performance-based restricted stock unit award granted on February 22, 2023. On February 25, 2026, the Compensation Committee certified a 15% reduction based on the Company's relative TSR performance over the three-year measurement period, resulting in 64 fewer shares than previously reported.

Around the same time

Michael D Shafer (Executive Vice President) sold ~$803K of Thermo Fisher Scientific

Scheduled in advanceFiled 7mo ago

Marc N CasperChairman & CEO

Filed 7mo ago

4,000Shares · @ $309.63

Traded Mar 5 · filed 4 days later

Derivative exercise or conversion — not an open-market buy.

More Official record

Marc N Casper (Chairman & CEO) sold ~$10K of Thermo Fisher Scientific

Scheduled in advanceFiled 7mo ago